Latest Breaking News On - Critical path - Page 1 : vimarsana.com

Smartwatches offer window into Parkinson's disease progression

New research adds to growing evidence that widely used and user-friendly consumer devices, in this instance an Apple Watch paired with an iPhone, can detect changes in Parkinson's symptoms over time in individuals in the early stages of the disease.

Donanemab: FDA Advisors Unanimously Recommend for Approval

The FDA Advisory Committee recommended donanemab, which could lead to its approval later this year.

Depot, water treatment plant expansion bids scrapped

After going through the process of soliciting bids for two major projects, the city rejected both during a special meeting Tuesday.

NASCAR Driver's Career Path Taking A Detour Through Europe

Interim chief becomes permanent CEO at CSAA Insurance Group

Asceneuron Joins Critical Path for Alzheimer's Disease Consortium

Asceneuron SA: Asceneuron Joins Critical Path for Alzheimer's Disease Consortium

Asceneuron Joins Critical Path for Alzheimer's Disease Consortium

EISAI TO PRESENT DATA ON LECANEMAB and OTHER ALZHEIMER'S DISEASE RESEARCH AT THE AD/PD™ 2024 ANNUAL MEETING

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today the company will present the latest findings on lecanemab (U.S. brand name: LEQEMBI®), Eisai's anti-amyloid beta (Aβ) protofibril* antibody for the treatment of Alzheimer's disease (AD), at the 2024 International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders (AD/PD™) from March 5-9 in Lisbon, Portugal, and virtually. The lecanemab data and additional research findings from Eis

Clock ticking as Fulton County hacking deadline looms